Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats

Neuroscience Research

Volumn 60, Issue 2, 2008, Pages 162-169

  Cui, Qiao Ling ^a   Yung, Wing Ho ^b   Chen, Lei ^a  

^a QINGDAO UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

6 Hydroxydopamine; Globus pallidus; Single unit recording; Substance P

Indexed keywords

NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; OXIDOPAMINE; SR 140333B; SUBSTANCE P; SUBSTANCE P [9 SARCOSINE, 11 OXYMETHIONINE]; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; GLOBUS PALLIDUS; MALE; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SINGLE UNIT ACTIVITY; WISTAR RAT;

ACTION POTENTIALS; ADRENERGIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; COMPULSIVE BEHAVIOR; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; GLOBUS PALLIDUS; MALE; MEDIAL FOREBRAIN BUNDLE; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; SUBSTANCE P; TROPANES;

EID: 38649090337     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2007.10.007     Document Type: Article

References (47)

1. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12 (1989) 366-375
2. Aosaki T., and Kawaguchi Y. Actions of substance P on rat neostriatal neurons in vitro. J. Neurosci. 16 (1996) 5141-5153
3. Barker R. Substance P and Parkinson's disease: a causal relationship?. J. Theor. Biol. 120 (1986) 353-362
4. Barker R. Substance P and neurodegenerative disorders. A speculative review. Neuropeptides 20 (1991) 73-78
5. Barker R. Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases. Rev. Neurosci. 7 (1996) 187-214
6. Bergman H., Feingold A., Nini A., Raz A., Slovin H., Abeles M., and Vaadia E. Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci. 21 (1998) 32-38
7. Bugiani O., Perdelli F., Salvarani S., Leonardi A., and Mancardi G.L. Loss of striatal neurons in Parkinson's disease: a cytometric study. Eur. Neurol. 19 (1980) 339-344
8. Chen L.W., Wei L.C., Liu H.L., Qiu Y., and Chan Y.S. Cholinergic neurons expressing substance P receptor (NK(1)) in the basal forebrain of the rat: a double immunocytochemical study. Brain Res. 904 (2001) 161-166
9. Chesselet M.F., and Delfs J.M. Basal ganglia and movement disorders: an update. Trends Neurosci. 19 (1996) 417-422
10. Cui Q.L., Yung W.H., Xue Y., and Chen L. Substance P excites globus pallidus neurons in vivo. Eur. J. Neurosci. 26 (2007) 1853-1861
11. de Ceballos M.L., Fernandez A., Jenner P., and Marsden C.D. Parallel alterations in Met-enkephalin and substance P levels in medial globus pallidus in Parkinson's disease patients. Neurosci. Lett. 160 (1993) 163-166
12. Diez-Guerra F.J., Richardson P.J., and Emson P.C. Subcellular distribution of mammalian tachykinins in rat basal ganglia. J. Neurochem. 50 (1988) 440-450
13. Fernandez A., de Ceballos M.L., Jenner P., and Marsden C.D. Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients. Neuroscience 61 (1994) 73-79
14. Gallagher A.W., Chahl L.A., and Lynch A.M. Distribution of substance P-like immunoreactivity in guinea pig central nervous system. Brain Res. Bull. 29 (1992) 199-207
15. Glowinski J., Kemel M.L., Desban M., Gauchy C., Lavielle S., Chassaing G., Beaujouan J.C., and Tremblay L. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2 and NK3 tachykinin receptors. Regul. Pept. 46 (1993) 124-128
16. Humpel C., Saria A., and Regoli D. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism. Eur. J. Pharmacol. 195 (1991) 107-114
17. Humpel C., and Saria A. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat. Neurosci. Lett. 157 (1993) 223-226
18. Ingham C.A., Hood S.H., van Maldegem B., Weenink A., and Arbuthnott G.W. Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway. Exp. Brain Res. 93 (1993) 17-27
19. Kelland M.D., Soltis R.P., Anderson L.A., Bergstrom D.A., and Walters J.R. In vivo characterization of two cell types in the rat globus pallidus which have opposite responses to dopamine receptor stimulation: comparison of electrophysiological properties and responses to apomorphine, dizocilpine, and ketamine anesthesia. Synapse 20 (1995) 338-350
20. Krasnova I.N., Bychkov E.R., Lioudyno V.I., Zubareva O.E., and Dambinova S.A. Intracerebroventricular administration of substance P increases dopamine content in the brain of 6-hydroxydopamine-lesioned rats. Neuroscience 95 (2000) 113-117
21. Kryzhanovskii G.N., Atadzhanov M.A., and Kucherianu V.G. Effects of substance P on experimental parkinsonian syndrome. Biull. Eksp. Biol. Med. 108 (1989) 404-407
22. Le Gal La Salle G., and Ben-Ari Y. Microiontophoretic effects of substance P on neurons of the medial amygdala and putamen of the rat. Brain Res. 135 (1977) 174-179
23. Levesque M., Bedard A., Cossette M., and Parent A. Novel aspects of the chemical anatomy of the striatum and its efferents projections. J. Chem. Neuroanat. 26 (2003) 271-281
24. Levesque M., Parent R., and Parent A. Cellular and subcellular localization of neurokinin-1 and neurokinin-3 receptors in primate globus pallidus. Eur. J. Neurosci. 23 (2006) 2760-2772
25. Maggi C.A., Patacchini R., Rovero P., and Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J. Auton. Pharmacol. 13 (1993) 23-93
26. Magnin M., Morel A., and Jeanmonod D. Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients. Neuroscience 96 (2000) 549-564
27. Mantyh P.W., Hunt S.P., and Maggio J.E. Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand. Brain Res. 307 (1984) 147-165
28. Mantyh P.W., and Hunt S.P. Changes in 3H-substance P receptor binding in the rat brain after kainic acid lesion of the corpus striatum. J. Neurosci. 6 (1986) 1537-1544
29. Martorana A., Fusco F.R., D'Angelo V., Sancesario G., and Bernardi G. Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra. Exp. Neurol. 183 (2003) 311-319
30. Mauborgne A., Javoy-Agid F., Legrand J.C., Agid Y., and Cesselin F. Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains. Brain Res. 268 (1983) 167-170
31. McNeill T.H., Brown S.A., Rafols J.A., and Shoulson I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res. 455 (1988) 148-152
32. Minabe Y., Emori K., Toor A., Stutzmann G.E., and Ashby C.R. The effect of the acute and chronic administration of CP 96 345, a selective neurokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording study. Synapse 22 (1996) 35-45
33. Mounir S., and Parent A. The expression of neurokinin-1 receptor at striatal and pallidal levels in normal human brain. Neurosci. Res. 44 (2002) 71-81
34. Nalivaiko E., Michaud J.C., Soubrié P., Le Fur G., and Feltz P. Tachykinin neurokinin-1 and neurokinin-3 receptor-mediated responses in guinea-pig substantia nigra: an in vitro electrophysiological study. Neuroscience 78 (1997) 745-757
35. Nini A., Feingold A., Slovin H., and Bergman H. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism. J. Neurophysiol. 74 (1995) 1800-1805
36. Otsuka M., and Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73 (1993) 229-308
37. Overton P., Elliott P.J., Hagan R.M., and Clark D. Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. Eur. J. Pharmacol. 213 (1992) 165-166
38. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego
39. Perez-Otano I., Herrero M.T., Luquin M.R., Obeso J.A., and Del Rio J. Chronic MPTP treatment reduces substance P and met-enkephalin content in the basal ganglia of the marmoset. Brain Res. 585 (1992) 156-160
40. Raz A., Vaadia E., and Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J. Neurosci. 20 (2000) 8559-8571
41. Rioux L., and Joyce J.N. Substance P receptors are differentially affected in Parkinson's and Alzheimer's disease. J. Neural Transm. Park Dis. Dement Sect. 6 (1993) 199-210
42. Ruskin D.N., Rawji S.S., and Walters J.R. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393. J. Pharmacol. Exp. Ther. 286 (1998) 272-281
43. Saffroy M., Torrens Y., Glowinski J., and Beaujouan J.C. Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites. Neuroscience 116 (2003) 761-773
44. Solis O., Limon D.I., Flores-Hernondez J., and Flores G. Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. Synapse 61 (2007) 450-458
45. Sutoo D., Yabe K., and Akiyama K. Quantitative imaging of substance P in the human brain using a brain mapping analyzer. Neurosci. Res. 35 (1999) 339-346
46. Walker R.J., Kemp J.A., Yajima H., Kitagawa K., and Woodruff G.N. The action of substance P on mesencephalic reticular and substantia nigral neurones of the rat. Experientia 32 (1976) 214-215
47. Wichmann T., and DeLong M.R. Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6 (1996) 751-758